Home > Insider Trading > Filing (0001104659-18-000222)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1297251	W David Dockhorn	C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612	Executive Vice President & Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-12-28	72,850	$11.73	72,850	No	4	M	Direct
Common Stock	Disposition	2017-12-28	68,614	$90.81	4,236	No	4	S	Direct
Common Stock	Disposition	2017-12-28	4,236	$91.22	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-12-28	72,850	$0.00	72,850	$11.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,422		2023-12-20	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.16 to $91.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $91.15 to $91.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
42,636 of the options vested on March 2, 2016 upon satisfaction of certain performance criteria and 30,214 of the options vested on November 16, 2016 upon satisfaction of certain other performance criteria.